Abstract: Compositions and methods are disclosed for filling prostheses for implantation into human soft tissue. The compositions comprise at least one nonionic surfactant, such as a polysorbate, which can be provided to fill a physiologically compatible shell or containment sac of the prosthesis. The liquid compositions of the present invention have a relatively high viscosity and are quickly absorbed from body tissues, metabolized and excreted with no known adverse effect. The compositions can be injected into the physiologically compatible shell either before, during or after the surgical implantation procedure.
Type:
Grant
Filed:
January 7, 1998
Date of Patent:
February 13, 2001
Assignee:
Advanced Research and Technology Institute, Inc.
Abstract: An orthodontic force measuring apparatus includes a dental replica which includes a first tooth replica and a second tooth replica. The first tooth replica is moveable relative to the second tooth replica. The apparatus also includes an orthodontic appliance secured to both the first tooth replica and the second tooth replica of the dental replica. The apparatus further includes a force measuring device operatively coupled to the first tooth replica. The force measuring device is configured so as to measure force exerted on the first tooth replica by the orthodontic appliance. A method of measuring orthodontic force is also disclosed.
Type:
Grant
Filed:
August 6, 1999
Date of Patent:
September 19, 2000
Assignee:
Advanced Research and Technology Institute, Inc.
Abstract: The present invention provides a method to prevent, inhibit, or reduce dental calculus deposits or formation on the teeth of a dental calculus forming animal comprising exposing the teeth to a food product comprising an acidulent amount of phosphoric acid, wherein said food product further comprises an amount of a polycarboxylic acid sequestering agent effective to prevent, inhibit, or reduce dental calculus deposits or formation. The present invention further provides the food products and the method of preparing the food products of said method.
Type:
Grant
Filed:
May 22, 1998
Date of Patent:
June 27, 2000
Assignee:
Advanced Research and Technology Institute, Inc.
Abstract: A technique to produce a device for generating an electric field is disclosed. This electric field may be customized to direct movement of charged particles in a predetermined manner. Moreover, this device is readily installed and removed from a charged particle analyzer to facilitate interchange with other devices capable of generating electric fields with different characteristics. The device may be provided by etching an electrically conductive layer clad to a flexible dielectric substrate to define a predetermined conductive pattern. This pattern is then oriented relative to a charged particle pathway and an electric potential applied to generate the desired electric field.
Type:
Grant
Filed:
September 25, 1997
Date of Patent:
March 21, 2000
Assignee:
Indiana University Advanced Research & Technology Institute Inc.
Abstract: The present invention includes purified and isolated quassinoids and synthetically derived quassinoid analogs based on a picrasane carbon skeleton. Novel sidechains at C-15 incorporating water solubilizing agents such as glycine are discussed. Therapeutic methods taking advantage of anticancer, antiviral, and herbistatic properties of these quassinoids are disclosed, including use against solid tumors and human immunodeficiency virus infected cells.
Type:
Grant
Filed:
May 1, 1997
Date of Patent:
October 12, 1999
Assignees:
Advanced Research and Technology Institute, Inc., The Board of Governors of Wayne State University, Purdue Reseach Foundation
Inventors:
Paul A. Grieco, D. James Morre, Thomas H. Corbett, Frederick A. Valeriote
Abstract: Devices and methods are disclosed for the percutaneous administration of a composition to a desired in vivo location. The composition comprises a biologically active substance and a pharmaceutically acceptable carrier. The pharmaceutically acceptable carrier is preferably non-solid and a polymer, which is preferably capable of being transformed into a gel, thus allowing timed-released delivery of the substance. A preferred use for this invention is to provide local delivery of biologically active substances for the prevention of restenosis following angioplasty or other blood vessel injury.
Type:
Grant
Filed:
March 13, 1997
Date of Patent:
April 13, 1999
Assignee:
Advanced Research And Technology Institute, Inc.
Abstract: The present invention includes purified and isolated quassinoids and synthetically derived quassinoid analogs based on a picrasane carbon skeleton. Novel sidechains at C-15 incorporating water solubilizing agents such as glycine are discussed. Therapeutic methods taking advantage of anticancer, antiviral, and herbistatic properties of these quassinoids are disclosed, including use against solid tumors and human immunodeficiency virus infected cells.
Type:
Grant
Filed:
June 13, 1997
Date of Patent:
December 15, 1998
Assignee:
Advanced Research and Technology Institute, Inc.
Inventors:
Paul A. Grieco, D. James Morre, Thomas H. Corbett, Frederick A. Valeriote
Abstract: Described are unique preferred enzyme coacervate compositions and their use in catalyzing the reaction of substrates to which the enzyme is specific. Preferred coacervates of the invention are complex coacervates formed by complexing enzymes with polyelectrolytes.
Type:
Grant
Filed:
June 21, 1994
Date of Patent:
November 10, 1998
Assignee:
Advanced Research and Technology Institute, Inc.
Inventors:
Paul L. Dubin, Barry B. Muhoberac, Jiulin Xia